The MarketWatch News Department was not involved in the creation of this content.-- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment ...
Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...
Novo Nordisk stock plunges 42% so far in 2025 as GLP-1 competition, price cuts, guidance trims and restructuring plans cloud ...
People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.
The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...
Novo Nordisk NOVO.B2.54%increase; green up pointing triangle filed for U.S. approval of a higher dose of its Wegovy weight-loss injection, with a decision expected within a month or two. The Danish ...
It’s evident that there is still a challenge with access to mental health support. There’s a provider shortage, and the available providers’ time slots fill up quickly. But more than that, receiving ...
Los Angeles, USA - April 4, 2023 Novo Nordisk only editorial Stock information on the logo of the office facade Novo Nordisk is offering Ozempic and Wegovy for $199 to $349 per month Nearly 1 in 5 U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback